Ghosh Anirvan's Form 4 filing
Unity Biotechnology, Inc. (UBX) · filed Feb 5, 2024
- Accession no.
- 0000950170-24-011232
- Filed
- Feb 5, 2024
- Trade date
- Feb 2, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.16K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ghosh AnirvanCIK 0001807437 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Common Stock, $0.0001 par value | SSaleDisposed | −680 | $1.71 | −$1,162.8 | 78,746 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.